# TriRx Huntsville Pharmaceutical Services, LLC – FDA Inspection, Aug 11, 2023

Source: https://www.keypedia.com/records/fda_inspections/trirx-huntsville-pharmaceutical-services-llc/3b33daf8-bfa6-437e-9d8f-1611b733a98f
Source feed: FDA_Inspections

> FDA inspection 1216782 of TriRx Huntsville Pharmaceutical Services, LLC, August 11, 2023. Classification: No Action Indicated (NAI). 13 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1216782
- Company Name: TriRx Huntsville Pharmaceutical Services, LLC
- Inspection Date: 2023-08-11
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1322326 - 2026-06-15](https://www.keypedia.com/records/fda_inspections/trirx-huntsville-pharmaceutical-services-llc/84548e82-46e0-4e70-b7ac-63ce50cfbc7f)
- FDA Inspection 1166895 - 2022-04-01
- FDA Inspection 978625 - 2016-04-21
- FDA Inspection 908381 - 2014-12-19
- FDA Inspection 891076 - 2014-08-01

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/jared-p-stevens/11cd48ff-e61f-4448-98be-efe2f8377fc1)

Company: https://www.keypedia.com/companies/trirx-huntsville-pharmaceutical-services-llc/bdf3220b-2a57-4125-b4ef-af4d1d9c9fa8

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
